A Ugandan scientist's trail camera footage has revealed new insights into how the deadly Marburg virus may spread through bat ...

An experimental vaccine for Marburg virus—a deadly cousin of the infectious agent that causes Ebola—can protect large animals from severe infections for up to a year with a single shot ...

A deadly, Ebola-like virus called Marburg is currently causing an outbreak in Rwanda. The country declared an outbreak of Marburg virus disease on Sept. 27 and has reported 58 confirmed cases and ...

Promising results have been published from the first human trial testing an experimental vaccine targeting the deadly Marburg virus. Flagged as a potential pandemic-causing virus, this is the ...

In the transcription of mRNAs from the negative-strand genome template, the glycoprotein gene of Ebola virus (EBOV; but not Marburg virus (MARV)) undergoes editing to produce soluble variants of ...

By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Marburg Virus Outbreak Puts Focus on Soligenix Vaccine Development Soligenix, Inc. (NASDAQ:SNGX) is developing ...

Marburg virus disease has killed 11 people and sickened 25 others in Rwanda, which declared an outbreak on Sept. 27.

An experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial.

A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial.

A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine ...